연구동향 분석

Comprehensive Clinical Study of Concurrent Chemotherapy Breathing IMRT Middle Part of Locally Advanced Esophageal Cancer

정재홍(Jae Hong Jung) 김승철(Seung Chul Kim) 문성권(Seong Kwon Moon) 2015년

논문상세정보
인용/피인용
' Comprehensive Clinical Study of Concurrent Chemotherapy Breathing IMRT Middle Part of Locally Advanced Esophageal Cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • 4dct 모의시뮬레이션
  • 4dct-simulation
  • docetaxel
  • esophageal cancer
  • gatingimrt
  • 도쎄탁실
  • 식도암
  • 호흡동조세기변조방사선치료
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,644 0

0.0%

' Comprehensive Clinical Study of Concurrent Chemotherapy Breathing IMRT Middle Part of Locally Advanced Esophageal Cancer' 의 참고문헌

  • Transhiatal esophagectomy: clinical experience and refinements
    Orringer MB Ann Surg 230 (3) : 392 ~ 400 [1999]
  • Three-dimensional display in nuclear medicine
    Wallis JW Med Imag IEEE Trans 8 (2) : 297 ~ 330 [1989]
  • The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study
    Prins MJ Ann Oncol 24 (5) : 1290 ~ 1297 [2013]
  • The management of respiratory motion in radiation oncology report of AAPM Task Group 76
    Keall PJ Med Phys 33 (10) : 3874 ~ 3900 [2006]
  • The clinical implementation of respiratory-gated intensity-modulated radiotherapy
    Keal P Med Dosim 31 (2) : 152 ~ 162 [2006]
  • Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer:Evidence of a radiation and chemotherapy dose response
    Geh JI Radiother Oncol 78 (3) : 236 ~ 234 [2005]
  • Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer:Evidence of a radiation and chemotherapy dose response
    Geh JI Radiother Oncol 78 (3) : 236 ~ 244 [2005]
  • Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy
    Button MR Int J Radiat Oncol Biol Phys 73 (3) : 818 ~ 823 [2009]
  • Role of positron emission tomography–computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
    Gillies RS Br J Surg 99 (2) : 239 ~ 245 [2012]
  • Radiosensitization of colon cancer cell lines by docetaxel: Mechanisms of action
    Dunne AL Oncol Res 14 (9) : 447 ~ 454 [2004]
  • Radiation dose-volume effects in the heart
    Gagliardi G Int J Radiat Oncol Biol Phys 76 : S77 ~ S85 [2010]
  • Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemo-radiotherapy
    Suzuki A Cancer 117 (21) : 4823 ~ 4833 [2011]
  • Prescribing, recording and reporting photon beam therapy
  • Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus
    Ilson DH J Clin Oncol 16 (5) : 1826 ~ 1834 [1998]
  • Phase II study of cisplatin and 5 fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516)
    Ishida K Jpn J Clin Oncol 34 (10) : 615 ~ 619 [2004]
  • Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma
    Gao XS Int J Radiat Oncol Biol Phys 67 (2) : 389 ~ 396 [2007]
  • Outcomes after transhiatal and transthoracic esophagectomy for cancer
    Chang AC Ann Thorac Surg 85 (2) : 424 ~ 429 [2008]
  • Oesophageal chemoradiotherapy in the UK: current practice and future directions
    Gwynne S Clin Oncol (R Coll Radiol) 25 (6) : 368 ~ 377 [2013]
  • Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: Results from a randomized controlled trial
    Teoh AY Ann Oncol 24 (1) : 165 ~ 171 [2012]
  • INT 0123(Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
    Minsky BD J Clin Oncol 20 (5) : 1167 ~ 1174 [2002]
  • Fraction size and dose parameters related to the incidence of pericardial effusions
    Martel MK Int J Radiat Oncol Biol Phys 40 (1) : 155 ~ 161 [1998]
  • Esophageal motion during radiotherapy: quantification and margin implications
    Cohen RJ Dis Esophagus 23 (6) : 473 ~ 479 [2010]
  • Esophageal cancer dose escalation using a simultaneous integrated boost technique
    Welsh J Int J Radiat Oncol Biol Phys 82 (1) : 468 ~ 474 [2012]
  • Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy
    Zhang Z Int J Radiat Oncol Biol Phys 61 (3) : 656 ~ 664 [2005]
  • Curative treatment of esophageal carcinoma: Current options and future developments
    Wolf MC Radiat Oncol 6 (1) : 55 ~ [2011]
  • Complication probability as assessed from dose-volume histograms
    Lyman JT Radiat Res Suppl 8 : S13 ~ S19 [1985]
  • Complete pathologic response after neoadjuvant chemo-radiotherapy for esophageal cancer is associated with enhanced survival
    Donahue JM Ann Thorac Surg 87 (2) : 398 ~ 398 [2009]
  • Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102
    Bedenne L J Clin Oncol 25 (10) : 1160 ~ 1168 [2007]
  • Capecitabine and oxaliplatin for advanced esophagogastric cancer
    Cunningham D N Engl J Med 362 (9) : 858 ~ 859 [2008]
  • Cancer statistics 2012
    Siegel R Cancer J Clin 62 (1) : 10 ~ 29 [2012]
  • Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method
    Kutcher GJ Int J Radiat Oncol Biol Phys 16 (6) : 1623 ~ 1630 [1989]
  • Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: Magnetic resonance evaluation
    Hatakenaka M Int J Radiat Oncol Biol Phys 83 (1) : e67 ~ e73 [2012]
  • A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501)
    Higuchi K Radiother Oncol 87 (3) : 398 ~ 404 [2008]
  • A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
    Webb S Phys Med Biol 38 (6) : 653 ~ 666 [1993]
  • 3D photon superposition/convolution algorithm and its foundation on results of Monte Carlo calculations
    Ulmer W Phys Med Biol 50 (8) : 1767 ~ 1790 [2005]